CLNPHARMA vs COGNOR
Side-by-side comparison of key ratios for CLNPHARMA and COGNOR.
Last updated: Source: ESEF / GPW
| Metric | CLNPHARMA CLN | COGNOR COG |
|---|---|---|
| P/E | — | 4.4 |
| EPS (TTM) | — | 1.34 |
| Dividend yield | — | — |
| Market cap | 1.13 mld | 1.16 mld |
This information is provided for informational purposes only and does not constitute investment advice or a recommendation. Listings describe companies by the stated criteria and are not an inducement to buy or sell any financial instrument. Verify figures against official sources before making any investment decision.